Institutional Review Board, Hospital for Special Surgery
The safety of our participants is our top priority. The trial/study is approved and periodically reviewed by the Institutional Review Board (IRB), which includes doctors, administrators, ethicists, and members of the general public. The safety of clinical trials is reviewed by the U.S. Food and Drug Administration.
Before enrolling in a clinical trial or research study, the investigator will explain the purpose of the trial/study, its expected benefits, any possible risks or side effects, and what your role will be. If you want to join the trial/study, you must sign informed consent documents. You can leave a trial/study at any time without penalty.
For further information, see Understanding Clinical Trials/Research Studies.
Thedore T. Miller, MD, FACR
Gregory R. Saboeiro, MD
Lorene Janowski, Occupational Therapist
Tracy Klein
Inclusion Criteria:
· Diagnosis of hemiplegic Cerebral Palsy with flexor tendon spasticity
· Patient of the principal investigator
· Age 2 years and older
· Able to understand the informed consent and sign consent/assent for themselves
Exclusion Criteria
· Prior surgeries on affected arm
· Patients who are unable to understand the informed consent and sign the consent/assent for themselves
Tracy Klein
KleinT@hss.edu
212.774.2727